Piper Jaffray Maintains Athena Health Overweight Rating And PT Of $46 (ATHN)

In a report published today, Piper Jeffray maintains its Athena Health ATHN Overweight rating and its $46 PT. In the report, Piper Jaffray states, "Our meeting with ATHN management offered some new updates on the Enterprise strategy, athenaclinicals, and the sales strategy. After a challenging 2010, CEO Jonathan Bush is "recharged" and aiming to gain market share in the Enterprise setting. A new President of the Enterprise Group, a focused strategy, and a healthy pipeline should bode well for deal flow and doc-adds in 2011. Incremental improvements in athenaclinicals workflow should help margins, and incremental investments in Sales & Marketing will be put to good use." Athena Health shares are trading at $41.33, -0.83% from Thursday's market close.